UNSPSC 51132235: Aspirin/calcium carbonate/magnesium carbonate/magnesium oxide

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN103. This VA Drug Class (CN103) classifies this compound as belonging to the group NON-OPIOID ANALGESICS.

UNSPSC 51132235 Aspirin/calcium carbonate/magnesium carbonate/magnesium oxide is a Commodity code that shows minimal recent activity aligned with its nominal scope. The single recent state-local opportunity posted under this code — Seminole County, Florida's IFB 60459723LAS — solicits naloxone and drug deactivation systems for community health initiatives, which falls entirely outside the code's stated pharmaceutical ingredients and antacid compounds. The mismatch indicates either misclassification by the issuing body or that the code does not currently capture meaningful procurement volume in state and local markets for the products it nominally describes.

Seminole County's June 2026 posting sought 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive sealed bidding, with quarterly deliveries to the county's community health building in Sanford, Florida and a July 26, 2023 response deadline. The contract carried a two-year initial term with a one-year renewal option, required E-Verify compliance and drug-free workplace certification, and was potentially funded through FEMA with associated federal compliance obligations. No additional recent opportunities under this code appear in the source, and the geographic spread and issuing-body mix cannot be characterized from a single posting outside the code's scope.